Switzerland is home to a thriving pharmaceutical industry. (Keystone) - Click to enlarge The United States Food and Drug Administration (FDA) published Thursday a list of pharmaceutical companies that include Basel-based Novartis and Roche, all of which are suspected of hindering the development of generic versions of their own medicines. Over 150 complaints were filed. The FDA slammed the development of techniques designed to complicate or even prevent developers of generic drugs from accessing sufficient quantities of original preparations to be able to do comparative studies essential to any application for approval. The authority said it has received more than 150 complaints over the alleged misuse of FDA
Topics:
Swissinfo considers the following as important: 3) Swiss Markets and News, Business, Featured, newsletter
This could be interesting, too:
Nachrichten Ticker - www.finanzen.ch writes Die Performance der Kryptowährungen in KW 9: Das hat sich bei Bitcoin, Ether & Co. getan
Nachrichten Ticker - www.finanzen.ch writes Wer verbirgt sich hinter der Ethereum-Technologie?
Martin Hartmann writes Eine Analyse nach den Lehren von Milton Friedman
Marc Chandler writes March 2025 Monthly
The United States Food and Drug Administration (FDA) published Thursday a list of pharmaceutical companies that include Basel-based Novartis and Roche, all of which are suspected of hindering the development of generic versions of their own medicines. Over 150 complaints were filed.
The FDA slammed the development of techniques designed to complicate or even prevent developers of generic drugs from accessing sufficient quantities of original preparations to be able to do comparative studies essential to any application for approval.
The authority said it has received more than 150 complaints over the alleged misuse of FDA programmes or agreements between pharmaceutical companies and distributors.
The FDA noted that it had not investigated these allegations.
Tags: Business,Featured,newsletter